Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

68 results about "Alpha-fetoprotein" patented technology

Alpha-fetoprotein (AFP, α-fetoprotein; also sometimes called alpha-1-fetoprotein, alpha-fetoglobulin, or alpha fetal protein) is a protein that in humans is encoded by the AFP gene. The AFP gene is located on the q arm of chromosome 4 (4q25).

T cell receptor targeting AFP peptide, preparation method thereof and companion diagnostic kit

The invention relates to the technical field of biological medicine, in particular to a T cell receptor targeting AFP peptide, a preparation method of the T cell receptor and a companion diagnostic kit. A T cell receptor targeting an AFP peptide is provided, the sequence of the AFP peptide is FMNKFIYEI, and the T cell receptor comprises a TCR [alpha] chain variable domain and a TCR [beta] chain variable domain. Corresponding nucleic acid molecules, vectors and host cells, and methods of making T cell receptors are provided. Further provided is a companion diagnostic kit containing the cell receptor. The invention provides a better choice for concomitant diagnosis and treatment products of cells of alpha fetoprotein (AFP).
Owner:BEIJING LIKANG LIFE SCIENCES & TECH CO LTD

Construction method and application of zwitter-ion antifouling and dual-signal-ratio electrochemical biosensor

PendingCN119125562Aprevent surface stickingImprove interface anti-fouling abilityBiological material analysisMaterial electrochemical variablesAptamerElectrochemical biosensor
The invention discloses a construction method and application of a zwitter-ion antifouling and dual-signal-ratio electrochemical biosensor, and belongs to the technical field of biochemical sensing analysis and life science. According to the invention, 3-aminopropyl dimethylamine oxide (APDMAO) zwitterions are prepared to be used as an antifouling interface. Specific positive and negative charges (N < + >-O-) of APDMAO promote hydrogen bond combination with water molecules, and a firm hydration barrier is formed. Meanwhile, the development of APDMAO overcomes the defect that zwitterions are difficult to synthesize and modify, and the application of APDMAO in biosensing analysis is expanded. A methylene blue (MB) internal standard modified alpha fetoprotein (AFP) aptamer is coupled with APDMAO under a controllable potential, so that the detection precision of the sensor is improved. The constructed ratio type electrochemical antifouling biosensor realizes sensitive and accurate detection of AFP, and the detection limit is as low as 3.41 fg / mL.
Owner:QINGDAO UNIV OF SCI & TECH

Application of 5 '-tiRNA-Lys-CTT as liver cancer serum early diagnosis marker

InactiveCN118995935AImprove 5-year survival rateGood discrimination effectMicrobiological testing/measurementDNA/RNA fragmentationEarly TherapyProtein
The invention provides application of 5 '-tiRNA-Lys-CTT as a liver cancer serum early diagnosis marker, and relates to the technical field of research and development of biological diagnosis reagents, the specific technical scheme is that the application of 5'-tiRNA-Lys-CTT as a detection target in preparation of liver cancer early diagnosis products, and specific verification experiments prove that the serum 5 '-tiRNA-Lys-CTT can be used for early diagnosis of liver cancer. Particularly, the 5 '-tiRNA-Lys-CTT is obviously up-regulated in serum and tumor tissues of a patient in the 0 / A stage of BCLC, which indicates that the 5'-tiRNA-Lys-CTT is closely related to the liver cancer. ROC analysis shows that the serum 5 '-tiRNA-Lys-CTT has a good distinguishing effect on a BCLC 0 / A stage liver cancer patient and a healthy person, the distinguishing effect is better than that of alpha fetoprotein and abnormal prothrombin (vitamin K deficiency or antagonist-II induced protein), and a new biomarker is provided for early diagnosis of the liver cancer patient. Serum samples are easy to obtain, and blood examination of suspected patients can be used as an early screening index, so that early treatment is facilitated, and the five-year survival rate of liver cancer is increased; and compared with imageology and invasive examination, the device is simpler and more convenient and can be accepted by patients.
Owner:AFFILIATED HOSPITAL OF NANTONG UNIV

Miniature optical fiber end face integrated chimney-shaped structure reflection type surface plasma resonance biosensor for ultra-sensitive alpha fetoprotein detection

The invention provides a detection method of an end face integrated reflection type SPR optical fiber biosensor manufactured based on a 2PP technology. An experiment system mainly comprises a single-mode optical fiber, an optical fiber coupler, an SPR probe, a tungsten lamp light source, a sample pool, a spectrum analyzer and a computer. The method is characterized in that a volcanic three-dimensional microstructure is directly constructed on the end face of a single-mode fiber through a 2PP technology, a metal film with the thickness of about 50nm is deposited on the inner wall of the volcanic three-dimensional microstructure, and a stable and efficient SPR excitation structure is formed; the structural parameters are subjected to FDTD simulation optimization design, and have the characteristics of high quality factor and high sensitivity. The sensor can be used for AFP detection, the sensitivity reaches 0.684 nm / (ng / mL) within the linear range of 0-10 ng / mL, the normal and risk early warning concentration interval of human serum AFP is covered, and the sensor has good biological suitability and early hepatocellular carcinoma screening capacity; in addition, the probe structure is small in size, detection can be completed only by a few microliters of liquid to be detected, and the probe is suitable for a microfluidic platform with an extremely low sample size or a clinical sampling scene. Compared with the prior art, the device has the advantages of high structural integration, high sensitivity, low sample consumption, convenience in manufacturing, stability, reliability and the like.
Owner:NORTHEASTERN UNIV AT QINHUANGDAO

Optical fiber microstructure biosensor for detecting alpha fetoprotein and preparation method thereof

The invention belongs to the technical field of optical fiber sensing, and provides an optical fiber microstructure biosensor for detecting alpha fetoprotein and a preparation method thereof, and the method comprises the following steps: step 1, synthesizing a gold nanorod; 2, selecting a single-mode optical fiber for real-time monitoring, removing a coating layer, placing the single-mode optical fiber in a fusion splicer, drawing to obtain a micro-conical optical fiber, enabling CO2 laser to act on a conical waist area of the micro-conical optical fiber to manufacture a cone, taking out the optical fiber, and cooling and curing to obtain an optical fiber microstructure sensor; step 3, immersing a sensing area of the optical fiber microstructure sensor into NaOH, washing and drying, and immersing the sensing area into an MPTMS-ethanol solution; washing is carried out, and then the sensing area is immersed in a GNRs-PEG-COOH solution; washing and drying, immersing the sensing area in an EDC / NHS mixed solution for soaking, washing and drying, and putting the sensing area in an mAb solution for soaking; and washing and drying to obtain the optical fiber microstructure biosensor.
Owner:ANHUI UNIV

T cell receptor targeting AFP peptide, preparation method thereof and companion diagnostic kit

The invention relates to the technical field of biological medicine, in particular to a T cell receptor targeting AFP peptide, a preparation method of the T cell receptor and a companion diagnostic kit. A T cell receptor targeting an AFP peptide is provided, the sequence of the AFP peptide is FMNKFIYEI, and the T cell receptor comprises a TCR [alpha] chain variable domain and a TCR [beta] chain variable domain. Corresponding nucleic acid molecules, vectors and host cells, and methods of making T cell receptors are provided. Further provided is a companion diagnostic kit containing the cell receptor. The invention provides a better choice for concomitant diagnosis and treatment products of cells of alpha fetoprotein (AFP).
Owner:BEIJING LIKANG LIFE SCIENCES & TECH CO LTD

Marker for evaluating curative effect of TACE combined with Czodili monoclonal antibody and bevacizumab in treatment of hepatocellular carcinoma, and construction method and application of FAAP prognostic scoring model

ActiveCN121068921AMedical data miningHealth-index calculationFetuin bTumor thrombus
The invention belongs to the technical field of medical diagnosis, and discloses a marker for evaluating the curative effect of treating hepatocellular carcinoma by combining TACE with Czodili monoclonal antibody and bevacizumab, and a construction method and application of an FAAP prognostic scoring model. The invention develops and verifies an FAAP prognostic scoring system, and a novel composite model integrates four indexes of fibrin degradation product / cholinesterase ratio * 1000 (FCR), aspartate aminotransferase (AST), alpha fetoprotein (AFP) and portal vein tumor thrombus (PVTT), and is used for predicting the survival condition of uHCC patients subjected to TACE-Czodimab-bevacizumab triple therapy. The tool has an instant clinical value, can optimize patient selection, guides adaptive treatment upgrading, and provides a standardized curative effect evaluation basis for a clinical test for exploring a TACE-immunotherapy-anti-angiogenesis combined scheme.
Owner:PEOPLES HOSPITAL PEKING UNIV

Preparation method of albumin oligopeptide and application of albumin oligopeptide in promotion of postoperative patient recovery

The invention relates to the technical field of albumin oligopeptides, in particular to a preparation method of albumin oligopeptides and application of the albumin oligopeptides in promotion of postoperative patient recovery. The albumin oligopeptide provided by the invention can be taken before, during or after an operation, not only can quickly promote postoperative recovery and reduce the content of total bilirubin and direct bilirubin of a patient, but also can reduce the activity of glutamic oxalacetic transaminase and glutamic-pyruvic transaminase, and also can reduce the activity of carbohydrate antigen 199 and the content of alpha fetoprotein. In addition, by taking the albumin oligopeptide, the bitter throat dryness can be improved, nausea and vomiting symptoms can be eliminated, and the albumin oligopeptide has the effect of promoting postoperative liver function recovery of obstructive jaundice.
Owner:HUBEI NUTRATIDE BIOTECH CO LTD

Nucleic acid aptamer capable of specifically recognizing serum alpha fetoprotein and application of nucleic acid aptamer

The invention belongs to the technical field of biomedical detection, and particularly discloses a nucleic acid aptamer for specifically recognizing serum alpha fetoprotein and application of the nucleic acid aptamer. The nucleotide sequence of the nucleic acid aptamer comprises a sequence as shown in SEQ ID No.1, or has more than 90% of homology with the sequence as shown in SEQ ID No.1, or one or more nucleotides are deleted or added in the sequence as shown in SEQ ID No.1. The nucleic acid aptamer can realize specific efficient recognition of AFP protein, also shows extremely high selectivity in a complex serum sample environment, eliminates non-specific adsorption interference of homologous protein and other serum interference protein, greatly reduces the false positive rate, and improves the accuracy and specificity of clinical detection. And the material constructed by directionally functionalizing the aptamer on the surface of the magnetic nano-carrier has rapid magnetic response performance, separation and enrichment of target protein can be realized within seconds, and the clinical diagnosis time is greatly shortened.
Owner:YING KE ZHONG KANG (XIA MEN) KE JI YOU XIAN GONG SI +1

Clinical decision support device, sample analysis system, and liver cancer risk assessment method

PCT designated stageWO2026138627A1Alpha-fetoproteinBiologic marker
A clinical decision support device, comprising: a parameter acquisition module, configured to acquire measured values for markers in a biomarker combination of a subject, wherein the biomarker combination at least comprises an alpha fetoprotein, an abnormal prothrombin, γ-glutamyltransferase, and an albumin; a risk assessment module, configured to input the measured values for the markers in the biomarker combination into a calculation model to obtain an output of the calculation model as a liver cancer risk prediction result of the subject; and an output module, configured to output the liver cancer risk prediction result of the subject. Also disclosed are a sample analysis system and a method for assessing a liver cancer risk of a subject, capable of better assessing a liver cancer risk of a subject.
Owner:SHENZHEN MINDRAY BIO MEDICAL ELECTRONICS CO LTD

T cell receptor targeting AFP peptide, its preparation method and companion diagnostic kit

The present invention relates to the field of biomedical technologies, and particularly to a T cell receptor targeting an AFP peptide, a preparation method thereof, and an accompanying diagnostic kit. A T cell receptor targeting an AFP peptide is provided, the sequence of the AFP peptide is FMNKFIYEI, and the T cell receptor comprises a variable domain of the TCRα chain and a variable domain of the TCRβ chain. Corresponding nucleic acid molecules, vectors, and host cells are provided, as well as a method for preparing the T cell receptor. An accompanying diagnostic kit containing the cell receptor is further provided. The present invention provides a better choice for products for the accompanying diagnosis and treatment of cells of alpha-fetoprotein (AFP).
Owner:BEIJING LIKANG LIFE SCIENCES & TECH CO LTD

Photoelectrochemical aptamer sensor for detecting alpha fetoprotein and preparation method thereof

The invention provides a photoelectrochemical aptamer sensor for detecting alpha fetoprotein and a preparation method of the photoelectrochemical aptamer sensor, and relates to the technical field of sensors. According to the invention, a solvothermal method and a chemical reduction method are combined to gradually load BiPO4 nanosheets and Ag NPs onto TiO2NRA, so that the Ag / BiPO4 / TiO2NRA ternary composite material is obtained. Through the synergistic effect of a Type II type n-n heterojunction formed by TiO2NRA and BiPO4 and the surface plasma resonance (SPR) effect of Ag, the utilization rate of a photoelectric material to visible light is increased, and the photoelectric property of the photoelectric material is improved, so that the sensitivity of a photoelectrochemical biosensor is improved, and the detection range of alpha fetoprotein to be detected is expanded. In addition, a Type II type n-n heterojunction constructed by BiPO4 and TiO2NRA improves the transfer rate of electrons, the SPR effect of metal Ag is combined with the Type II type n-n heterojunction structure, a visible light source is utilized to a great extent, the photoelectric property of the photoelectrochemical aptamer sensor is improved, the sensitivity of the alpha fetoprotein photoelectrochemical aptamer sensor is further improved, and the detection limit is lower.
Owner:QIQIHAR UNIVERSITY

Rare earth nano probe, preparation method and application

The invention discloses a rare earth nanoprobe, a preparation method and application thereof, and belongs to the technical field of biomedical detection.According to the technology, the rare earth nanoprobe with the high fluorescence quantum yield is synthesized, specific recognition of tumor markers is achieved through the aptamer technology, and the detection sensitivity and selectivity are remarkably improved. The fluorescence signal amplification effect of the rare earth nanoprobe and the modern fluorescence detection technology are innovatively combined, so that simultaneous detection of multiple tumor markers such as carcino-embryonic antigen (CEA), prostate specific antigen (PSA) and alpha fetoprotein (AFP) becomes possible. According to the method, the detection limit reaches the pg / mL level, the operation is simple and convenient, the cost is low, and the feasibility of clinical application is greatly improved. Besides, through multiple detection design, the detection efficiency and accuracy are further improved, an effective tool is provided for early diagnosis, curative effect monitoring and prognosis evaluation of tumors, and wide clinical application prospects and market potential are shown.
Owner:HOSPITAL OF STOMATOLOGY XIAN JIAOTONG UNIVERSITY

Sensing method for detecting double tumor markers CEA (carcino-embryonic antigen) and AFP (alpha-fetoprotein) on surfaces of living cells through ultra-sensitive in-situ electrochemiluminescence

The invention provides a living cell surface double-tumor marker in-situ detection method based on a closed bipolar electrode (cBPE) array and an electrochemiluminescence (ECL) technology. The living cell surface double-tumor marker in-situ detection method is used for synchronously quantifying carcino-embryonic antigen (CEA) and alpha-fetoprotein (AFP). According to the system, the high specific surface area, the ordered porous structure and the rich surface amino active sites of a covalent organic framework (COF) material are utilized, and the excellent conductivity and biocompatibility of gold nanoparticles (Au NPs) are combined, so that the bifunctional signal probe COF (at) Au (at) MBApt is constructed. The probe can simultaneously load a large number of signal molecule methylene blue (MB) and is coupled with a targeting aptamer (Apt), so that high-capacity labeling and specific recognition of a target marker are realized.
Owner:LIAOCHENG UNIV

Preparation method and application of ternary heterojunction composite photoelectrochemical immunosensor

The application relates to a preparation method and application of a ternary heterojunction composite photoelectrochemical immunosensor, and belongs to the technical field of photoelectrochemical biosensors, and particularly relates to a preparation method and application of a photoelectrochemical immunosensor for detecting alpha-fetoprotein by adopting a BiPO4 / BiOBr / CdS composite material. The method is characterized in that a ternary heterojunction is assembled on an FTO modified electrode to fix a capture antibody, and the accurate determination of alpha-fetoprotein is realized through a photocurrent signal response. The BiPO4 / BiOBr heterojunction expands the forbidden band width and expands the light absorption range; due to the sensitization of CDs, the absorption of visible light is enhanced, so that the photocurrent signal is increased. The method has the advantages of good stability, strong specificity, high sensitivity, good reproducibility and the like, is good for the rapid detection of alpha-fetoprotein, solves the existing technical difficulties, and provides a feasible method for the detection of tumor markers.
Owner:SHENYANG PHARMA UNIV

Microfiltration device for alpha fetoprotein variant detection

The invention relates to the technical field of detection, in particular to a microfiltration device for alpha fetoprotein heteroplasmon detection, a limiting baffle ring is arranged at the top of a supporting head in a microfiltration head component, corresponding limiting is provided for placement of a filter membrane, and the filter membrane is in contact with the inner side wall of the limiting baffle ring, so that a gap is prevented from being generated, and the detection accuracy of alpha fetoprotein heteroplasmon detection is improved. The working efficiency of filtering and adsorbing the alpha fetoprotein heterogeneous is improved, and the positive effect is achieved on the accuracy of subsequent detection work; an auxiliary assembly is further arranged in the supporting head part, so that the filter membrane can be better taken out, and the phenomenon that the filter membrane is easily damaged when the filter membrane is clamped by tweezers from the middle part of the filter membrane is avoided; in addition, an auxiliary pressing ring in the arranged volume cup assembly also has an extrusion limiting effect on the filter membrane, namely the problem that the filter membrane shakes when liquid is poured in is avoided, and the working stability of the filter membrane is improved; and the method has positive significance in improving the detection and filtering work efficiency of the alpha fetoprotein variant.
Owner:TIANJIN BAIJI BIOTECHNOLOGY CO LTD

A homogeneous chemiluminescence kit for determining alpha-fetoprotein content

The present invention relates to the technical field of immunoassay detection, and in particular to a homogeneous chemiluminescence kit for determining the content of alpha-fetoprotein. The kit includes an alpha-fetoprotein specific antibody 1 labeled with a probe D and an alpha-fetoprotein specific antibody 2 labeled with a probe K. The preparation method of the alpha-fetoprotein specific antibody 1 labeled with the probe D includes the steps of: mixing a polymer with a nanogel solution to obtain a probe D, mixing the alpha-fetoprotein specific antibody 1 with the probe D, and obtaining the alpha-fetoprotein specific antibody 1 labeled with the probe D; the preparation method of the alpha-fetoprotein specific antibody 2 labeled with the probe K includes the steps of: mixing a polymer with an MOF solution to obtain a probe K, mixing the alpha-fetoprotein specific antibody 2 with the probe K, and obtaining the alpha-fetoprotein specific antibody 2 labeled with the probe K. The kit of the present invention effectively improves the accuracy and sensitivity of the determination.
Owner:WITTMAN MEDICAL LAB (NANJING) CO LTD

A method for constructing an AFP-L3% electrochemical biosensor and application thereof

The application belongs to the field of biosensors, and provides a construction method and application of an electrochemical biosensor for quantifying AFP-L3% (AFP-L3 / AFP), and the specific process is as follows: Au@UiO-66 nanocomposites are obtained by using a hydrothermal method and an immersion reduction method, TCEP can open S-S in alpha-fetoprotein to obtain sulfydryl (-SH) and connect to Au@UiO-66, in-situ synthesis of AFP aptamer-copper clusters (Apt-CuNCs) is carried out by using DNA as a template, Apt-CuNCs are used to recognize total AFP, the content of total AFP is determined by using the generated Cu electrochemical signal, then, the Apt-CuNCs are subjected to enzymatic cleavage and stripping by using exonuclease I, alpha-fetoprotein heterogeneity (AFP-L3) is labeled by using lentil agglutinin (LCA) functionalized silver nanoparticles LCA@AgNPs, the content of AFP-L3 is determined by using the generated Ag electrochemical signal, and AFP-L3% can be calculated by combining the data of the two, and the electrochemical biosensor constructed by the method can be used for determining AFP-L3% in human serum.
Owner:NANJING NORMAL UNIVERSITY

Systems and methods for diagnosing hepatocellular carcinoma based on the detection and interpretation of a panel of micrornas in a subject

A system for generating a hepatocellular carcinoma (HCC) report for a subject based on blood-based molecular profiling is provided. The system includes a sample preparation module configured to process a blood sample by isolating both plasma and serum fractions. A nucleic acid extraction module extracts a microRNA (miRNA) profile from the plasma fraction, and a real-time PCR module detects and quantifies the expression levels of a predefined panel of miRNAs, including miR-361-5p, miR-130a-3p, miR-27a-3p, miR-30d-5p, and miR-193a-5p. The expression levels of the predefined panel of miRNAs are used by a trained machine learning classifier to generate a HCC risk classification categorizing the subject into one of HCC risk levels. An alpha-fetoprotein (AFP) level detected and quantified from the serum fraction may also be used in combination with the miRNA expression levels in the HCC risk classification for enhanced prediction accuracy.
Owner:CITY UNIVERSITY OF HONG KONG

Composite magnetic nano material as well as preparation method and application thereof

PendingCN119033958AEnergy modified materialsDigestive systemCarcinoembryonic Antigen AntibodyMagnetotactic bacterium
The invention discloses a composite magnetic nano material as well as a preparation method and application thereof. The composite magnetic nano material is a magnetosome chain which is coated with an alpha fetoprotein antibody or a carcino-embryonic antigen antibody and is doped with Er < 3 + > generated by magnetotactic bacteria. The Er < 3 + >-doped magnetosome chain which is coated by the alpha fetoprotein antibody or the carcino-embryonic antigen antibody and is generated by the magnetotactic bacteria can be used for treating cancers.
Owner:ZHEJIANG LAB

Reagent composition for liver cancer detection, kit and application

The invention relates to the technical field of biological detection, and discloses a reagent composition for liver cancer detection, a kit and application. The reagent composition provided by the invention comprises a combination of primers and probes for detecting the methylation states of the FAM109B gene, the RIMS2 gene, the SNX31 gene, the FAR1 gene and the FLJ26850 gene, so that the methylation state of a specific target sequence in the liver cancer characteristic gene can be detected, and the detection sensitivity and specificity of the liver cancer are at a relatively high level. The reagent composition provided by the invention can be used for noninvasive liver cancer screening, and during liver cancer screening, compared with conventional liver ultrasound and alpha fetoprotein combined detection, the detection sensitivity is greatly improved, the early screening accuracy of liver cancer is improved, and the misdiagnosis rate and missed diagnosis rate are greatly reduced.
Owner:CENT SOUTH UNIV +1

High affinity antibodies specifically binding to alpha-1, 6-core-fucosylated alpha fetoprotein

The present invention relates to monoclonal antibodies and antigen binding fragments that specifically bind to an alpha-1, 6-core-fucosylated alpha fetoprotein (AFP), which is a core component of AFP-L3. Thus, the antibodies and antigen binding fragments provided herein may also be referred to as AFP-L3 antibodies. Also provided are polynucleotides encoding the antibodies or antigen-binding fragments of the invention, host cells expressing the antibodies and antigen-binding fragments of the invention, methods for producing the antibodies and antigen-binding fragments of the invention, and uses of the antibodies and antigen-binding fragments of the invention. Also provided herein are pretreatment agents that promote the binding of the antibodies and antigen binding fragments of the invention to alpha-1, 6-core-fucosylated AFP. The invention further relates to kits comprising the antibodies and antigen binding fragments of the invention and optionally a pre-treatment agent of the invention.
Owner:F HOFFMANN LA ROCHE & CO AG

Methods to manipulate alpha-fetoprotein (AFP)

As demonstrated herein, soluble human FcRn binds to AFP with affinities greater than observed with albumin, and is able to interfere with FcRn-mediated protection of and functional associations with IgG. Accordingly, provided herein, in some aspects, are compositions and methods to inhibit FcRn and AFP interactions in diseases or disorders where elevated AFP levels are associated with immunosuppression. Also provided herein, in some aspects, are compositions and methods to enhance or potentiate FcRn and AFP interactions in diseases or disorders with decreased AFP levels or diseases or disorders where increasing AFP levels increasing with immunosuppression.
Owner:THE BRIGHAM & WOMEN S HOSPITAL INC

Visual quantitative analysis method for alpha fetoprotein in saliva

The invention belongs to the technical field of alpha fetoprotein visual quantitative analysis, and particularly relates to a visual quantitative analysis method for alpha fetoprotein in saliva, a double-recognition multiple-quenching molecular imprinting and electrochemical luminescence microscope is constructed, and MI-ECLM takes self-developed SECLM as a signal output device and comprises a molecular imprinting polymer and a double-mechanism quencher; preparing a saliva sample and performing pretreatment; the pretreated saliva sample is placed on an MI-ECLM sensor, and an optical image is obtained through electrochemical luminescence imaging; and analyzing the optical image to realize visual quantitative detection of alpha fetoprotein in saliva.
Owner:GUANGXI NORMAL UNIV

Alpha fetoprotein detection test strip based on directional coupling of nano antibody as well as preparation method and application of alpha fetoprotein detection test strip

The invention discloses an alpha fetoprotein detection test strip based on directional coupling of a nano antibody as well as a preparation method and application of the alpha fetoprotein detection test strip. A combination pad of the test strip is coated with a detection marker and a quality control marker; the detection marker comprises a Spytag alpha fetoprotein nano antibody and a SpyCatcher fluorescent microsphere, and the detection marker comprises a Spytag alpha fetoprotein nano antibody and a SpyCatcher fluorescent microsphere; the Spytag alpha fetoprotein nano antibody is formed by fusing a Spytag polypeptide and an alpha fetoprotein nano antibody, and the SpyCatcher fluorescent microsphere is composed of a fluorescent microsphere and a SpyCatcher protein modified on the fluorescent microsphere; the Spytag at alpha fetoprotein nano antibody and the SpyCatcher at fluorescent microspheres are in directional coupling through the Spytag and the SpyCatcher. The alpha fetoprotein nano antibody and the SpyTag polypeptide form the fusion protein, and then the fusion protein and the fluorescent microsphere with the surface modified with the SpyCatcher protein form a covalent bond through Spytag / SpyCatcher specificity, so that the alpha fetoprotein nano antibody is directionally modified on the surface of the fluorescent microsphere, and an alpha fetoprotein recognition site is fully exposed, so that the biological activity of the detection marker can be effectively improved; further, the detection specificity and sensitivity are improved.
Owner:GUANGZHOU MEDICAL UNIV +1

Preparation method of multicolor fluorescent carboxylated carbon nano quantum dot biological probe for detecting hepatocellular cancer

The invention relates to the technical field of fluorescent probe preparation, and discloses a preparation method of a multicolor fluorescent carboxylated carbon nano quantum dot biological probe for detecting hepatocellular cancers, and the preparation method comprises the following steps: S1, preparing nanoscale multicolor fluorescent carbon dots; s2, preparation of aminated nano-scale multicolor fluorescent carbon dots; s3, preparation of carboxylated nano-scale multicolor fluorescent carbon dots; s4, preparing an alpha fetoprotein rabbit antibody; s5, confirming alpha fetoprotein rabbit anti-interaction site subunits and constructing related gene libraries and plasmids; and S6, carrying out a biological coupling reaction. According to the method, the sensitivity and specificity of hepatocellular cancer detection can be improved, the reliability of hepatocellular cancer detection can be improved, the detection cost can be reduced, the early diagnosis rate of hepatocellular cancer can be improved, hepatocellular cancer can be detected earlier, the early diagnosis rate of hepatocellular cancer can be improved, and the death rate of hepatocellular cancer can be reduced.
Owner:SHUIMU HELEI (SUZHOU) BIOMEDICAL CO LTD

Intelligent prediction system and method for early recurrence risk after liver cancer thermal ablation

The invention discloses an intelligent prediction system and method for early recurrence risk after liver cancer thermal ablation, and aims to solve the technical problem that prediction is not timely and inaccurate due to the fact that an existing prediction model ignores intraoperative dynamic information. According to the method, dynamic time sequence data such as tissue impedance and power in the thermal ablation process are collected in real time, and preoperative static data such as tumor size and alpha fetoprotein level are combined, so that a double-branch fusion prediction model is constructed. The model comprises a time sequence processing branch used for learning dynamic data time dependence and a static processing branch used for extracting static data features. By fusing the features of the two branches, the model can output a probability value representing the postoperative early recurrence risk. According to the method and the system, instant accurate risk stratification after operation is realized, and further, intraoperative intervention can be guided through real-time feedback, so that the early recurrence risk is actively reduced, and the prognosis of a patient is improved.
Owner:GUANGDONG GENERAL HOSPITAL +1

Detection method for early hepatocellular carcinoma and reagent set used in detection method

The invention discloses a method for detecting early hepatocellular carcinoma and a reagent set used by the method. The detection method comprises the following steps: performing biomarker identification of a group of methylated genes with difference in a computing system; performing, in a computing system, a quantitative measurement of the degree of methylation from the selected plurality of biomarkers in the group using a quantitative methylation-specific polymerase chain reaction; executing a formula calculation in the calculation system according to the methylation degree of the selected biomarker to obtain an M score of the selected biomarker; and performing a risk level assessment of hepatocellular carcinoma using the resulting M fraction or a combination of M fraction and serum alpha fetoprotein in a computing system.
Owner:YUNXIANG INVESTMENT CONSULTING CO LTD

Early liver cancer postoperative recurrence prediction model and method based on radiomics phenotype

The invention relates to the technical field of medical imaging omics analysis, and discloses an early-stage liver cancer postoperative recurrence prediction model and method based on imaging omics phenotypes, and the method comprises the following steps: data collection and preprocessing, feature screening and standardization, model construction, model verification and risk layering. The data acquisition and preprocessing is to obtain preoperative enhanced CT image data and clinical information of an early-stage hepatocellular carcinoma (HCC) patient meeting the agralan standard, and the clinical information comprises serum alpha fetoprotein (AFP) level and tumor number. According to the image omics phenotype-based early liver cancer postoperative recurrence prediction model and method, pre-operation and post-operation dual models are constructed by integrating pre-operation enhanced CT image omics characteristics (including first-order statistics, texture and wavelet characteristics), clinical parameters (such as serum alpha fetoprotein and tumor number) and post-operation pathological variables (such as microvascular invasion and satellite nodules).
Owner:季顾惟

An optoelectrochemical detection device and application based on radiation modulation

The present invention discloses a photoelectrochemical detection device and application based on radiation modulation, belonging to the technical field of photoelectrochemical sensing and biological detection; a detection device applicable to the detection of alpha-fetoprotein, comprising a photoelectrochemical biosensor and a photoelectrochemical test device; the photoelectrochemical biosensor includes an ATA thin film electrode; the ATA thin film electrode includes an FTO substrate; a Au film layer is provided on the upper surface of the FTO substrate, and a TiO2 film layer is provided on the upper surface of the Au film layer; a AuNPs layer is deposited on the TiO2 film layer; the photoelectrochemical test device includes an optical chopper connected to a lock-in amplifier; the lock-in amplifier is connected to a low-pass filter; the optical chopper is arranged between the light source and the photoelectrochemical biosensor; the photoelectrochemical biosensor is connected to the low-pass filter through an electrochemical workstation; the present invention uses lock-in amplification combined with the ATA thin film electrode to enable the detection of the analyte to have a lower detection limit and a larger detection range.
Owner:TAIYUAN UNIVERSITY OF TECHNOLOGY